Heart 2000;83:511–517
Abnormal cardiopulmonary exercise variables inasymptomatic relatives of patients with dilatedcardiomyopathy who have left ventricularenlargement
N G Mahon, S Sharma, P M Elliott, M K Baig, M W Norman, S Barbeyto,W J McKenna
Abstract Background—Left ventricular enlargement with normal systolic function is common in asymp- tomatic relatives of patients with familial dilated cardiomyopathy, many of whom progress to overt dilated cardiomyopathy at follow up. Objective—To examine maximal and submaximal gas exchange variables of cardiopulmonary exercise testing in asymptomatic relatives with left ventricular enlargement. Design and setting—Controlled evaluation of metabolic exercise performance of patients with dilated cardiomyopathy and asymptomatic relatives with left ventricular enlargement identified through prospective family screening in a cardiomyopathy outpatient clinic. Methods—23 relatives with left ventricular enlargement, 33 normal controls, 29 patients with dilated cardiomyopathy, and 10 elite athletes with echocardiographic criteria of left ventricular enlargement (“physiological” enlargement) underwent symptom limited upright cycle ergometry using a ramp protocol. Results—Peak oxygen consumption (pVO ; mean (SD)) was significantly reduced in relatives
with left ventricular enlargement (78 (16.3)%) v normal controls (96%, p < 0.01) and athletes(152%, p < 0.001), but was higher than in patients with dilated cardiomyopathy (69%, p < 0.01). pVO was less than 80% of predicted in 75% of patients, 58% of relatives, 22% of controls, and
none of the athletes. Oxygen pulse (pVO /heart rate) was less than 80% of predicted in 69% of
patients, 35% of relatives, 6% of controls, and none of the athletes. The slope of minute ventila-tion v CO production ( VE/ VCO ) was > 30 in 68% of patients, 50% of relatives, and in none
of the controls or athletes. Anaerobic threshold, occurring in relatives at 37 (14)% of thepredicted VO , was higher than in the patients (32%, p < 0.01) and lower than in the controls
(45%, p < 0.05) or in the athletes (55%, p < 0.001). Conclusions—Maximal and submaximal cardiopulmonary exercise test variables are abnormal in asymptomatic relatives with left ventricular enlargement, in spite of normal systolic function. This provides further evidence that left ventricular enlargement represents subclinical disease in relatives of patients with dilated cardiomyopathy. Metabolic exercise testing can complement echocardiography in identifying relatives at risk for the development of dilated cardiomyopathy. (Heart 2000;83:511–517)
Keywords: cardiomyopathy; exercise; diagnosis
Idiopathic dilated cardiomyopathy usually de-
cific antibodies, as well as raised circulating
velops insidiously and is often advanced at the
isoforms.5 A recent three year follow up study
patients referred to hospital is poor, with a
25–30% one year mortality and a 50% five year
develops in 27% of patients with left ventricu-
mortality.1 The ability to identify early disease
would be a significant advance in the current
Patients with dilated cardiomyopathy have
Department of
management of this disease and facilitate stud-
abnormal maximal and submaximal responses
Cardiological
to cardiopulmonary exercise testing,7 involving
Sciences, St George’s Hospital Medical School, Cranmer
dilated cardiomyopathy has identified a subset
hypothesised that asymptomatic left ventricu-
Terrace, London
of relatives who have left ventricular enlarge-
lar enlargement in the relatives of such patients
SW17 ORE, UK
ment (defined as a left ventricular diastolic
cardiopulmonary exercise capacity, in contrast
predicted for age and body surface area2 in the
to cardiopulmonary performance in individu-
presence of normal systolic function, and in the
als with physiological left ventricular enlarge-
absence of an underlying cause such as hyper-
ment caused by athletic training. Our aim in
tension or athletic training.3 4) Left ventricular
this study was thus to examine maximal and
enlargement in a relative of a patient with
dilated cardiomyopathy may be a marker of
exercise testing in those relatives of cardiomy-
early or mild disease. Relatives with left
opathy patients found to have left ventricular
ventricular enlargement have a higher than
expected prevalence of circulating heart spe-
patients with overt dilated cardiomyopathy,
normal controls, and athletes with “physiologi-
underwent clinical assessment, 12 lead ECG,
cal” dilatation of the left ventricle as a result of
EXERCISEAll patients and controls were fasted for two
hours before exercise testing. Exercise was per-
formed in the upright position on a Sensor-
Twenty three consecutive asymptomatic rela-
tives with left ventricular enlargement, from 19
families attending a tertiary referral centre
protocol ranging from 10–15 watts/min (se-
lected to ensure adequate stress and avoid pre-
went metabolic exercise testing. They were
mature fatigue) in a quiet air conditioned room
with an average temperature of 21°C and full
dilated cardiomyopathy being followed up dur-
resuscitation facilities. Each test was super-
ing the same period. Evaluation of asympto-
vised by an experienced cardiologist, nurse,
matic relatives was performed with local ethics
committee approval and has been described in
Before the test all patients underwent a three
detail elsewhere.6 Left ventricular enlargement
minute practice run at zero work rate. A respi-
was defined as an unexplained left ventricular
ratory exchange ratio below 0.85 was required
before starting the test. Simultaneous breath by
than 112% of predicted in the presence of a
breath gas exchange analysis was performed
shortening fraction of greater than 25%.6
using a dedicated Sensormedics metabolic cart
Predicted left ventricular end diastolic dimen-
sion (LVEDDc) was calculated according to
Linda, California, USA). Respiratory gas was
sampled continuously from a mouthpiece and
LVEDDc = [45.3 × BSA0.3] − [0.03 × age]
transducer for oxygen and a 2900 MMC non-
dispersive infrared sensor for carbon dioxide.
The signals underwent analogue to digital con-
version for the calculation of oxygen consump-
diomyopathy was defined according to World
Health Organization criteria9; in addition, all
(VCO ) using an established technique.11 Meas-
patients with dilated cardiomyopathy had an
urements included VO (l/min), VCO (l/min),
LVEDD of > 112% of predicted, with a short-
minute ventilation (VE), heart rate (beats/
ening fraction of < 25%. Patients with coron-
min), work rate (WR; watts), and respiratory
ary disease, hypertension, valvar disease, or a
quotient. Graphs of VO v VCO to calculate
regular alcohol intake of > 21 units/week in
calculate aerobic work eYciency, VE v VO ,
excluded. All relatives with left ventricular
oxygen pulse v VO , and heart rate v VO were
enlargement filled in a questionnaire about
generated by an IBM computer (Sensormedics
Vmax/Vision software) using on line gasexchange data from the metabolic cart, each
variable being plotted at 10 second intervals.
Forty five volunteers with a normal 12 lead
Signals from a 12 lead ECG were displayed
bolic exercise testing under identical condi-
tions. All volunteers were required to fill in a
(Marquette Electronics Inc, Milwaukee, Wis-
questionnaire about their daily physical activ-
consin, USA). Blood pressure was measured by
ity. Individuals performing more than two
auscultation at the brachial artery at one
hours of organised physical training a week
minute intervals during exercise and for the
first three minutes after exercise, using a
fulfilled echocardiographic criteria for leftventricular enlargement were also evaluated.
An elite athlete was defined as an individual
who had attained a suYciently high standard
The peak oxygen consumption (pVO ), defined
in his or her sport to compete at international
as the highest oxygen consumption achieved
during exercise, was calculated by measuringthe mean of the highest values over the last 10
seconds of exercise. To allow for age, body size,
All subjects underwent conventional two di-
and sex diVerences,12 results were expressed as
a percentage of the predicted maximum oxygen
weeks before the exercise test. End diastolic
consumption (VO max), which was calculated
and end systolic diameters were measured from
using established nomograms based on age,
the short axis views at the level of the tips of the
sex, height, and weight.13–15 Values below 80%
mitral valve leaflets, and shortening fraction
fall below established 95% confidence limits
was derived from these measurements.10 All
and were considered abnormal.16 The anaero-
echocardiograms were analysed blind to the
bic threshold was calculated non-invasively
clinical diagnosis. All patients with dilated car-
using the V slope method17 and expressed as a
diomyopathy and left ventricular enlargement
percentage of the predicted VO max. Values
Metabolic exercise in left ventricular enlargement
under 40% were considered abnormal.18 The
per cent of athletes, 69% of patients with
oxygen pulse (O pulse) was calculated as the
dilated cardiomyopathy, 60% of relatives with
quotient of the pVO and peak heart rate. Values
were expressed as a percentage of the maxi-
was 26 (12.2) years in athletes (range 15–54),
formulae for predicted VO max and predicted
46 (12.6) years in patients (19–70), 32 (12.6)
maximum heart rate.19 Values below 80% of
years in relatives (17–62), and 34 (12.8) years
predicted were considered abnormal. Values
in controls (15–66). Two relatives with left
above 80% were regarded as normal provided
ventricular enlargement who undertook more
the individual had achieved a maximum heart
than two hours of structured physical activity a
rate of at least 80%. The work rate (WR) in
watts at peak exercise was determined andexpressed as a percentage of the predicted
maximum work rate calculated according to
Baseline echocardiographic data for all four
LVEDD% in relatives with left ventricular
Expired volume v expired CO was plotted
enlargement was 118.4 (5). This did not diVer
graphically, and the relation ( VE/ VCO ) was
significantly from LVEDD% of either athletes
calculated as the slope below the point of
or patients with dilated cardiomyopathy, but
anaerobic threshold. The normal gradient of
the slope is 26–30.22 A respiratory quotient of
(p < 0.001). Fractional shortening (FS) in
relatives with left ventricular enlargement was
31 (4.4)%; this was lower than in normal con-
excluded from the study. Six patients with
trols (37 (5.3)%, p < 0.001) and higher than in
dilated cardiomyopathy and two relatives with
the patients (17 (4.4)%, p < 0.001).
left ventricular enlargement were excluded onthis basis.
Statistical analysis was performed using SPSS
Most of the patients with dilated cardiomyopa-
for Windows (SPSS Inc, Chicago, Illinois,
USA). All variables were tested for normality of
(NYHA) functional class I (10 (36)%) or II (16
(54)%); three patients (10%) were in class III.
The patients were all symptomatic at presenta-
dent’s t test, analysis of variance,
tion. All of them were on angiotensin convert-
Mann–Whitney U test, Kruskall–Wallis test,
ing enzyme inhibitors, 45% were on diuretics,
and bivariate correlation tests were used where
appropriate. A value of p < 0.05 was consid-
ered significant. Metabolic and echocardio-
angiotensin II antagonists. All the relatives
graphic results were expressed as absolute
values and as percentages of predicted values to
minimise diVerences resulting from age and sex
Nineteen of the patients with cardiomyopa-
disparities. Results are expressed as mean
thy (66%) were in sinus rhythm and 10 (34%)
had atrial fibrillation; six (20%) had left axisdeviation on the ECG, and five (17%) had left
bundle branch block. Non-sustained ventricu-
lar tachycardia (three or more ventricular
exercise testing without complication. Seventy
ectopic beats at a rate of > 120 beats/min) was
Echocardiographic and metabolic exercise data (all groups)
*Comparison with LVE group. †Per cent of normal standard. AT, anaerobic threshold (% of predicted VO max); DCM, dilated cardiomyopathy; FS, fractional shortening; HRmax, maximum heart rate; LVE, left ventricular
enlargement; LVEDD, left ventricular end diastolic dimension; O pulse, quotient of pVO and peak heart rate; pVO , peak oxygen consumption; PET CO pressure
of end tidal carbon dioxide; RQ, respiratory quotient; VE, minute ventilation.
documented at initial assessment in 11 (39%)
of the patients. The asymptomatic subjects
with left ventricular enlargement were all in
controls (45%, p = 0.02) or the athletes (55%,
sinus rhythm. The relatives with left ventricular
p < 0.001). Anaerobic threshold occurred at
less than 40% of the predicted VO max in 75%
of the patients, 65% of the relatives, 22% of the
controls, and none of the athletes (table 2).
Metabolic exercise variables are shown for allfour groups in table 1. Maximum heart rate
(per cent predicted) in the relatives did not dif-
fer significantly from controls or athletes but
was higher than in the patients (92 (9.8)% v 89
When all 103 subjects were analysed together,
(15)%, p = 0.02). Relatives achieved 83 (20)%
modest correlations were observed between
of their predicted maximum work rate v 63%
fractional shortening and O pulse (r = 0.49,
(p < 0.004) in the patients, 104% (p = 0.001)in normal controls, and 156% (p < 0.001) in
athletes. Similar significant diVerences wereobserved when absolute values (beats/min andwatts respectively) were analysed (table 1).
The results are shown in fig 1. Oxygen pulse inthe relatives was 89 (17)% of predicted, whichwas lower than that observed in normalcontrols
(167%, p < 0.001), and higher than in the
patients (70%, p < 0.01). O pulse was less
than 80% of predicted in 69% of the patients,in 35% of the relatives, in 6% of the controls,and in none of the athletes (table 2). One
patient and one relative had an O pulse that
Boxplot of oxygen pulse values for each group,showing median, quartiles, and 95th centiles. Dashed line
because of a low maximum heart rate. In 40%
represents 80% of predicted oxygen pulse.
of the patients and 46% of the relatives theoxygen pulse did not increase in the expected
parabolic pattern23 but began to plateau belowthe anaerobic threshold. In these patients,heart rate increased more rapidly at the point offlattening. Peak oxygen uptakeThe results are shown in fig 2. pVO
significantly reduced in the relatives (78
(16.3)%) compared with the normal controls
(96%, p < 0.01) and the athletes (152%,p < 0.001), and was higher than in the patients(69%, p < 0.01). Similar significant diVerences
were observed when absolute values in ml/kg/
min were analysed (table 1). Peak oxygen con-
Boxplot of p VO per cent predicted for eachgroup, showing median, quartiles, and 95th centiles. Dashed
patients, in 58% of the relatives, in 22% of the
line represents 80% of predicted p VO .
controls, and in none of the athletes (table 2).
The results are shown in fig 3. The slope of theminute ventilation as a function of VCO below
creased in the patients, with a mean value of 34
in controls and at the upper limit of normal in
the relatives. Sixty eight per cent of the patientsand 50% of the relatives had a
slope of > 30. No normal controls and no ath-letes had a value above 30 (table 2).
The results are shown in fig 4. Anaerobic
threshold occurred at a mean of 37 (14)% of
showing median, quartiles, and 95th centiles. Dashed line
the predicted VO max in the relatives, which
represents the normal slope of 30.Metabolic exercise in left ventricular enlargementPrevalence of abnormal results within each group
including changes in peripheral blood flow,ratios of type I to type II muscle fibres, and
mitochondrial density, which are observed in
patients with dilated cardiomyopathy and heart
failure25 26—may also occur in left ventricular
enlargement. However, as arteriovenous oxy-
gen diVerence is generally increased in heart
failure in spite of the changes described above,
a reduction in the relatives is unlikely.
*Per cent predicted. AT, anaerobic threshold; DCM, dilated cardiomyopathy;
HRmax, maximum heart rate; LVE, left ventricular enlarge-
ment; O pulse, quotient of pVO and peak heart rate; pVO , peak
oxygen consumption; VE, minute ventilation.
possibility of peripheral mechanisms for re-duced exercise performance in relatives with
(r = −0.49, p < 0.001), maximum
VCO was normal in the relatives, 46% had a
threshold (r = 0.42, p < 0.001), NYHA class
documented in patients with congestive car-
(r = −0.50, p < 0.001), and WR% (r = 0.53,
diac failure,27–29 but the mechanisms of this
p < 0.001). LVEDD% correlated poorly with
increased ventilatory response are controver-
metabolic measurements, even when athletes
sial. Ventilation–perfusion mismatch reflecting
increased pulmonary dead space caused bypulmonary vascular abnormalities has been
Discussion
proposed.30 This is supported by the finding
The results show that asymptomatic relatives of
that end tidal CO was normal in all patients in
patients with dilated cardiomyopathy, and who
this study. However, relatives with left ventricu-
also have left ventricular enlargement, have
lar enlargement who do not have heart failure
significantly abnormal cardiopulmonary exer-
are unlikely to have pulmonary vascular abnor-
cise test results. This adds to the serological
and immunological evidence that left ventricu-
involved include augmented chemosensitiv-
lar enlargement represents early disease in
ity,31 an enhanced ergoreflex causing direct
some individuals. While the mechanisms of
stimulation of ventilation by muscle activity,32
abnormal responses remain speculative, this
and reduced ability to increase gas transfer on
study suggests that both cardiac and peripheral
exercise.33 Similar reflexes may be involved in
the regulation of peripheral blood flow andcould be responsible for the abnormal oxygen
Although baseline systolic function was normal
suggests that asymptomatic relatives may not
in the relatives, analysis of the oxygen pulse
only be developing subtle cardiac abnormali-
pattern suggests that abnormalities of cardio-
ties but also have more widespread changes
aVecting cardiovascular performance.
caused by impaired augmentation of systolicfunction in response to exercise. Oxygen pulse
is the product of stroke volume and arteriov-
enous oxygen diVerence.16 The peak oxygen
The contrast between results obtained in the
relatives and in the athletes reinforces the view
relatives. In 46% of the relatives (compared
that left ventricular enlargement in relatives is
with 40% of the patients) the oxygen pulse
an indicator of underlying pathology. Left ven-
started to plateau with increasing work rate
tricular enlargement in athletes is common and
instead of rising in its normal parabolic
represents a normal physiological response to
fashion. One possible mechanism for an early
intensive physical training. Of 515 elite athletes
plateau of oxygen pulse is the failure of stroke
evaluated at this institution, 32% had echocar-
volume to increase. In patients with dilated
cardiomyopathy and left ventricular enlarge-
ment who had abnormally flat oxygen pulse
consumption observed in athletes with left
responses, the plateau occurred at or shortly
ventricular enlargement who underwent car-
after the anaerobic threshold. This phenom-
diopulmonary exercise testing suggests that it is
enon has previously been described in patients
not the ventricular enlargement per se that is
with hypertrophic cardiomyopathy23 and may
responsible for the cardiopulmonary abnor-
malities observed in the relatives, and further-
metabolic acidaemia because of a depressed
more that metabolic exercise testing may be a
useful method of distinguishing physiologicalfrom pathological left ventricular enlargement.
PERIPHERAL MECHANISMSAn alternative explanation for the reduced
pVO and oxygen pulse in the relatives would be
The definition of left ventricular enlargement
a reduction in arteriovenous oxygen diVerence
as “enlargement with normal systolic function”
in these individuals. Alterations that could
should be qualified by the recognition that
while systolic function is within normal limits
in these patients it is lower than in normal con-
1 Diaz RA, Obasohan O, Oakley CM. Prediction of outcome
Br Heart J 1987;58:393–9.
2 Henry WL, Gardin JM, Ware JH. Echocardiographic meas-
urements in normal subjects from infancy to old age. Circu-
exclusively by dilatation but is accompanied by
lation 1980;62:1054–61.
3 Michels VV, Moll PP, Miller FA, et al. The frequency of
evidence of a decline in systolic function, which
familial dilated cardiomyopathy in a series of patients with
nonetheless remains within normal limits, such
idiopathic dilated cardiomyopathy. N Engl J Med 1992;326: 77–82.
that left ventricular enlargement is the more
4 Keeling PJ, Gang Y, Seo H, et al. Familial dilated cardiomy-
striking finding. Isolated depressed fractional
opathy in the United Kingdom. Br Heart J 1995;73:417– 21.
shortening is also a recognised finding when
5 Marriott JB, Goldman JH, Keeling PJ, et al. Abnormal cyto-
relatives are evaluated, but this is less common
kine profiles in patients with idiopathic dilated cardiomy- opathy and their asymptomatic relatives. Heart 1996;75:
and is not clearly associated with risk of
6 Baig MK, Goldman JH, Caforio AL, et al. Familial dilated
cardiomyopathy: cardiac abnormalities are common in
asymptomatic relatives and may represent early disease. J
sumption is normally distributed within the
Am Coll Cardiol 1998;31:195–201.
7 Chua TP, Ponikowski P, Harrington D, et al. Clinical corre-
population. As a result, overlap between groups
lates and prognostic significance of the ventilatory response
is evident from the data. However, statistical
to exercise in chronic heart failure. J Am Coll Cardiol 1997;
analysis shows that metabolic indices in each
29:1585–90.
8 Harrington D, Coats AJ. Mechanisms of exercise intoler-
group lie on a continuum, with athletes at one
ance in congestive heart failure. Curr Opin Cardiol 1997;12:
end and patients with cardiomyopathy at the
9 Richardson P, McKenna W, Bristow M, et al. Report of the
other. The intermediate location of relatives
1995 World Health Organization/International Society and
with left ventricular enlargement, between nor-
Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:
mal controls and patients, is consistent with the
hypothesis that left ventricular enlargement
10 Schiller NB, Shah PM, Crawford M, et al. Recommenda-
tions for quantitation of the left ventricle by two-
represents mild or early dilated cardiomyopa-
dimensional echocardiography. American Society of Echo-
cardiography Committee on Standards, Subcommittee on
Quantitation of Two-Dimensional Echocardiograms. J Am
normally distributed, metabolic exercise test-
Soc Echocardiogr 1989;2:358–67.
ing cannot in isolation identify abnormal
11 Jones N. Evaluation of a microprocessor-controlled exercise
testing system. J Appl Physiol 1984;57:1312–19.
relatives, but may provide useful additional
12 Jones NL, Summers E, Killian KJ. Influence of age and stat-
information in the appropriate clinical context.
ure on exercise capacity during incremental cycle ergom- etry in men and women. Am Rev Respir Dis 1989;140:
Relatives with left ventricular enlargement who
performed more than two hours of organised
13 Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake
and nomographic assessment of functional aerobic impair-
physical activity a week were not specifically
ment in cardiovascular disease. Am Heart J 1973;85:546–
excluded from our analysis. This could have
biased this group towards better metabolic
14 Cooper DM, Weiler-Ravell D, Whipp BJ, et al. Aerobic
parameters of exercise as a function of body size during
indices, in contrast to the controls in whom this
growth in children. J Appl Physiol 1984;56:628–34.
was a specific exclusion criterion. The two
15 Astrand I, Astrand PO, Hallback I, et al. Reduction in maxi-
mal oxygen uptake with age. J Appl Physiol 1973;35:649–
relatives who exceeded this level of activity had
16 Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise
O of 95% and 80.5%, respectively. In con-
testing and interpretation, 2nd ed. Philadelphia: Lee and
trast, the lowest pVO among the athletes with
17 Beaver WL, Wasserman K, Whipp BJ. A new method for
detecting anaerobic threshold by gas exchange. J ApplPhysiol 1986;60:2020–7.
Finally, although the use of cycle ergometry
18 Hansen JE, Sue DY, Wasserman K. Predicted values for
clinical exercise testing. Am Rev Respir Dis 1984;129:S49–
may have limited the attainable pVO , particu-
larly among athletes, all predicted values were
19 Jones NL. Clinical exercise testing, 3rd ed. Philadelphia: WB
20 Hansen JE, Sue DY, Oren A, et al. Relation of oxygen uptake
as related to work rate increment during cycle ergometer exercise. Eur J Appl Physiol 1988;57:140–5.
21 Jones NL. Clinical exercise testing, 3rd ed. Philadelphia: WB
Although systolic function is within normal
22 Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise
limits, asymptomatic relatives with left ven-
testing and interpretation, 2nd ed. Philadelphia: Lea andFebiger, 1994:117–19.
tricular enlargement have significant abnor-
23 Jones S, Elliott PM, Sharma S, et al. Cardiopulmonary
malities on metabolic exercise testing. Analysis
responses to exercise in patients with hypertrophic cardio- myopathy. Heart 1998;80:60–7.
of maximal and submaximal variables suggests
24 Winter UJ, Gitt AK, Blaum M, et al. Cardiopulmonary
capacity in patients with coronary heart disease. Z Kardiol 1994;83(suppl 3):73–82. [In German.]
advanced disease may be involved, including
25 LeJemtel TH, Maskin CS, Lucido D, et al. Failure to
alterations in ventilatory reflexes. These abnor-
augment maximal limb blood flow in response to one-legversus two-leg exercise in patients with severe heart failure.
malities contrast with the supranormal results
Circulation 1986;74:245–51.
in athletes, who have a similar degree of left
26 Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in
patients with stable chronic heart failure: eVects on
ventricular enlargement. This adds to serologi-
cardiorespiratory fitness and ultrastructural abnormalities
of leg muscles. J Am Coll Cardiol 1995;25:1239–49.
ventricular enlargement represents early or
gas exchange abnormalities on exercise in chronic heart
mild disease in some individuals. Metabolic
failure. Eur Respir J 1995;8:2022–8.
exercise testing could form part of a clinical
ventilation mismatch during exercise in chronic heart
algorithm for the detection and risk stratifica-
failure: an investigation of circulatory determinants. Br
tion of relatives who have early dilated cardio-
Heart J 1995;74:27–33.
29 Chua TP, Coats AJ. The lungs in chronic heart failure. EurHeart J 1995;16:882–7.
30 Sullivan MJ, Higginbotham MB, Cobb FR. Increased exer-
cise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988;77:552–9.
We gratefully acknowledge the assistance of Mary Gould, Carol
31 Chua TP, Clark AL, Amadi AA, et al. Relation between
Page, and Brian Mist. Sanjay Sharma and Mark W Norman
chemosensitivity and the ventilatory response to exercise in
were supported by British Heart Foundation junior fellowships.
chronic heart failure. J Am Coll Cardiol 1996;27:650–7. Metabolic exercise in left ventricular enlargement
32 Piepoli M, Clark AL, Volterrani M, et al. Contribution of
33 Messner-Pellenc P, Brasileiro C, Ahmaidi S, et al. Exercise
muscle aVerents to the hemodynamic, autonomic, and
intolerance in patients with chronic heart failure: role of pul-
ventilatory responses to exercise in patients with chronic
monary diVusing limitation. Eur Heart J 1995;16:201–9.
heart failure: eVects of physical training. Circulation
34 Sharma S, Elliot PM, Whyte G, et al. Cardiac dimensions in
1996;93:940–52.
junior elite athletes. Heart 1998;79(suppl 1):40.
Mid-ventricular HOCM with apical asynergy
A 45 year old woman presented with recurrent
was sparing of the basal septum and the apex
episodes of rapid non-sustained palpitations
was not hypertrophied but rather thinned,
and associated dizziness. She had no significant
asynergic, and aneursymal (fig 1). No throm-
medical history or family history of cardiac
disease. Examination revealed a soft systolic
abnormalities were present. Colour Doppler
murmur. ECG showed sinus rhythm with left
revealed a turbulent jet in both systole and
ventricular hypertrophy on voltage criteria and
early diastole with flow from apex to base.
inferolateral T wave changes. Transthoracic
echocardiography demonstrated the unusual
systolic flow away from the transducer (apical
finding of mid-ventricular hypertrophic ob-
four chamber position), then mid-ventricular
structive cardiomyopathy with systolic cavity
cavity obstruction with no flow, followed by a
obliteration at the papillary muscle level and an
high early diastolic velocity (4 m/s) and flow
associated intracavity velocity of 4 m/s. There
from apex to base concurrent with the mitralinflow E wave. This paradoxical early diastolicflow is thought to represent blood trapped inthe apical cavity in systole, which subsequentlyleaves
ventricular obstruction is no longer present.
Several patterns of hypertrophic cardiomy-
opathy (HCM) have now been clearly defined. The apical variant constitutes 25% of all HCMin the Japanese population, but only 1–2% ofthe HCM cases in non-Japanese patients. Mid-ventricular HCM with apical asynergy is some-what less common. In the largest publishedreport to date, a Japanese team reported anincidence of concealed apical aneurysm with
Apical two chamber view demonstrating
mid-ventricular cavity obliteration of approxi-
mid-ventricular obstruction and an apical aneurysm.
mately 1.5% of all HCM cases. The incidencein non-Japanese patients is yet to be clarified. The importance of this variant is its associationwith ventricular arrhythmias and systemicembolism, the latter occurring in 30% ofpatients. Identification of the paradoxical earlydiastolic flow from apex to base can be a
Department of
marker of a sequestered apical chamber in
Cardiology, King’s
patients with cavity obliteration, particularly
College Hospital,
when the apical cavity cannot readily be delin-
Denmark Hill, London
eated by cross sectional echocardiography. SE5 9RS, UK J C Cooke
Following the echocardiographic findings in
this patient, a 24 hour Holter monitor was per-
formed and revealed self limiting runs ofsupraventricular tachycardia along with ven-
Continuous wave Doppler trace from an apical
tricular couplets, but no ventricular tachycar-
four chamber position revealing the mid-ventricular
dia. Her palpitations are now controlled on
obstruction with cessation of flow followed by paradoxical
Description Drugline is a full-text data base offering problem-oriented drug evaluation comparable to a clinical consultation. Drugline is produced by the Karolinska Drug Information Center (Karolic), Department of Clinical Pharmacology, Karolinska University Hospital in cooperation with the regional drug information centers in Sweden, Denmark and Finland (ULIC, Uppsala; Elinor, Umeå;
Applying Evidence-Based Guidelines to Primary Care Dermatology Friday 2:00 PM, Concurrent Session E, Workshop WE04 Presenters: Jessica Zmolik, MD; Laura Zakowski, MD; Shobhina Chheda, MD, MPH, FACP University of Wisconsin School of Medicine and Public Health Findings: Open and/or closed comedones and inflammatory lesions, such as papules, pustules, and nodules Topical therapies: